Stephen Barat is Senior VP of Therapeutics of HTG MOLECULAR DIAGNOSTICS, INC. Currently has a direct ownership of 421 shares of HTGM, which is worth approximately $143. The most recent transaction as insider was on Jun 08, 2023, when has been sold 888 shares (Common Stock) at a price of $0.8 per share, resulting in proceeds of $710. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 421
0% 3M change
0% 12M change
Total Value Held $143

Stephen Barat Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 08 2023
SELL
Open market or private sale
$710 $0.8 p/Share
888 Reduced 67.84%
421 Common Stock
Mar 31 2023
SELL
Payment of exercise price or tax liability
$140 $2.7 p/Share
52 Reduced 3.82%
1,309 Common Stock
SB

Stephen Barat

Senior VP of Therapeutics
Tucson, AZ

Track Institutional and Insider Activities on HTGM

Follow HTG MOLECULAR DIAGNOSTICS, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HTGM shares.

Notify only if

Insider Trading

Get notified when an Htg Molecular Diagnostics, Inc insider buys or sells HTGM shares.

Notify only if

News

Receive news related to HTG MOLECULAR DIAGNOSTICS, INC

Track Activities on HTGM